Ethicon

Johnson & Johnson, through its subsidiary Ethicon, Inc., has entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies for lung cancer, for approximately $3.4 billion in cash, with additional contingent payments of up to $2.35 billion.

Johnson & Johnson subsidiary Ethicon won a $39 million contract from the US Department of Defense to supply medical surgical products to the Army, Navy, Air Force, Marine Corps and federal civilian agencies. The contract has a one-year base with nine one-year option periods and a performance completion date of November 2, 2027.

Grifols has signed an agreement to exclusively manufacture and supply plasma-derived products for the biosurgery field to Ethicon Inc., with an initial term of 10 years and subsequent 5-year renewal periods.

Ethicon, a Johnson & Johnson company, announced an agreement to acquire Torax Medical, Inc. No financial details were disclosed.